Directory
>
Bruce Belanger
Bruce Belanger
Vice President, Biostatistics | Atea Pharmaceuticals, Inc
Arlington, Massachusetts, United States
Bruce Belanger
Summary
Bruce Belanger is an accomplished Vice President of Biostatistics at Atea Pharmaceuticals, Inc., with a robust background in biostatistics and data management. With over three decades of experience in the pharmaceutical industry, he has held leadership roles at several prominent companies, including Ipsen and Genzyme. Bruce's expertise spans across various sectors of drug development, focusing on statistical methodologies that drive clinical research. He holds a PhD in Statistics from North Carolina State University and a BA in Mathematics from Boston University. His career reflects a commitment to advancing biostatistical practices and improving patient outcomes through data-driven insights. Bruce is known for his strategic thinking and ability to lead teams through complex projects in high-pressure environments. Outside of work, he is passionate about mentoring the next generation of statisticians and biostatisticians. His journey exemplifies dedication to both professional growth and community engagement.
Bruce Belanger
Work Experience
Vice President, Biostatistics at
Atea Pharmaceuticals, Inc
October 2020 - Present
Senior Director, Biostatistics, Due Diligence at
Ipsen
April 2017 - October 2020
Vice President, Biometrics, Development and Registration at
Merrimack Pharmaceuticals Cambridge
July 2014 - March 2017
Senior Director, Biostatistics at
Merrimack
September 2011 - July 2014
Senior Director, Biostatistics at
Tolerx, Inc.
April 2009 - April 2011
Sr Director, Biostatistics and Data Management at
Idenix Pharmaceuticals
September 2005 - April 2009
Director, Statistics at
Sanofi
August 2004 - September 2005
Director, Statistics at
Praecis Pharmaceuticals Inc
March 2000 - August 2004
Manager, Statistics at
Schering-Plough Research Institute
October 1994 - March 2000
Graduate Research Fellow at
Becton Dickinson Research Center
January 1990 - January 1994
Bruce Belanger
Education
Frequently Asked Questions about Bruce Belanger
What is Bruce Belanger email address?
Bruce Belanger's primary email address is **************@ateapharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Bruce Belanger work for?
Bruce Belanger is a Vice President, Biostatistics at Atea Pharmaceuticals, Inc, a company specializing in Commercial physical research.
Where Bruce Belanger graduated from?
Bruce Belanger holds a degree in Mathematics from Boston University.
How can I directly contact Bruce Belanger?
To contact Bruce Belanger directly, you can use the email address **************@ateapharma.com. Complete contact information is available upon registration with Muraena.
Who is Bruce Belanger?
Bruce Belanger is an accomplished Vice President of Biostatistics at Atea Pharmaceuticals, Inc., with a robust background in biostatistics and data management. With over three decades of experience in the pharmaceutical industry, he has held leadership roles at several prominent companies, including Ipsen and Genzyme. Bruce's expertise spans across various sectors of drug development, focusing on statistical methodologies that drive clinical research. He holds a PhD in Statistics from North Carolina State University and a BA in Mathematics from Boston University. His career reflects a commitment to advancing biostatistical practices and improving patient outcomes through data-driven insights. Bruce is known for his strategic thinking and ability to lead teams through complex projects in high-pressure environments. Outside of work, he is passionate about mentoring the next generation of statisticians and biostatisticians. His journey exemplifies dedication to both professional growth and community engagement.
Bruce`s contact details
**************@ateapharma.com
Colleagues
Executive Vice President, Chemistry
Executive Director - CMC, Process Chemistry, and cGMP Manufacturing
VP, Clinical Operations and Project Management
SVP, Investor Relations and Corporate Communications
Executive Vice President
Vice President, Business Development
EVP and Chief Accounting Officer
Executive Director, Regulatory Affairs